Manufacturer:
UCB, Inc.
Route of Administration:
Subcutaneous
Site of Care:
Outpatient
Website:
phone:
1-866-424-6942
Approved Indication:
- reducing signs and symptoms of Crohn’s disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy
- treatment of adults with moderately to severely active rheumatoid arthritis/strong>
- treatment of active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older
- treatment of adult patients with active psoriatic arthritis
- treatment of adults with active ankylosing spondylitis
- treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation
- treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy
Conditions:
- Ankylosing Spondylitis
- Crohn’s Disease
- Juvenile Idiopathic Arthritis
- Non-Radiographic Axial Spondyloarthritis
- Plaque Psoriasis
- Psoriatic Arthritis
- Rheumatoid Arthritis
Therapeutic Area:
- Dermatology
- Gastroenterology
- Rheumatology